103 related articles for article (PubMed ID: 17218774)
1. Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival.
Ghaneie A; Zemba-Palko V; Itoh H; Itoh K; Sakamuro D; Nakamura S; Soler AP; Prendergast GC
Cancer Biol Ther; 2007 Feb; 6(2):192-4. PubMed ID: 17218774
[TBL] [Abstract][Full Text] [Related]
2. Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression.
Chang MY; Boulden J; Sutanto-Ward E; Duhadaway JB; Soler AP; Muller AJ; Prendergast GC
Cancer Res; 2007 Jan; 67(1):100-7. PubMed ID: 17210688
[TBL] [Abstract][Full Text] [Related]
3. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
4. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.
Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M
Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969
[TBL] [Abstract][Full Text] [Related]
6. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity.
Ge K; Duhadaway J; Sakamuro D; Wechsler-Reya R; Reynolds C; Prendergast GC
Int J Cancer; 2000 Feb; 85(3):376-83. PubMed ID: 10652430
[TBL] [Abstract][Full Text] [Related]
7. Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast.
Son BH; Ahn SH; Ko CD; Ka IW; Gong GY; Kim JC
Breast J; 2004; 10(1):20-6. PubMed ID: 14717755
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of GLTSCR2 expression is correlated with breast cancer progression.
Moon A; Lim SJ; Jo YH; Lee S; Kim JY; Lee J; Park JH
Pathol Res Pract; 2013 Nov; 209(11):700-4. PubMed ID: 24054033
[TBL] [Abstract][Full Text] [Related]
9. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.
Zhao T; Miao Z; Wang Z; Xu Y; Wu J; Liu X; You Y; Li J
Tumour Biol; 2013 Oct; 34(5):2891-7. PubMed ID: 23686806
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression.
Prasad CP; Gupta SD; Rath G; Ralhan R
Oncology; 2007; 73(1-2):112-7. PubMed ID: 18337623
[TBL] [Abstract][Full Text] [Related]
12. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
13. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
14. Stat5: from breast development to cancer prognosis, prediction, and progression.
Tweardy D; Chang JC
J Clin Oncol; 2011 Jun; 29(18):2443-4. PubMed ID: 21576641
[No Abstract] [Full Text] [Related]
15. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
16. Reduced PTEN expression is associated with poor outcome and angiogenesis in invasive ductal carcinoma of the breast.
Lee JS; Kim HS; Kim YB; Lee MC; Park CS; Min KW
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):205-10. PubMed ID: 15551732
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of the suppressor gene bin1/amphiphysin2 accentuates the neoplastic character of transformed mouse fibroblasts.
Muller AJ; DuHadaway JB; Donover PS; Sutanto-Ward E; Prendergast GC
Cancer Biol Ther; 2004 Dec; 3(12):1236-42. PubMed ID: 15611650
[TBL] [Abstract][Full Text] [Related]
18. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
[TBL] [Abstract][Full Text] [Related]
19. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
Peurala E; Koivunen P; Bloigu R; Haapasaari KM; Jukkola-Vuorinen A
Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
[TBL] [Abstract][Full Text] [Related]
20. HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients.
Seki H; Hayashida T; Jinno H; Hirose S; Sakata M; Takahashi M; Maheswaran S; Mukai M; Kitagawa Y
Ann Surg Oncol; 2012 Jun; 19(6):1831-40. PubMed ID: 22396001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
